Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands

被引:225
作者
Cao, Yihai [1 ]
机构
[1] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden
关键词
ENDOTHELIAL-GROWTH-FACTOR; FACTOR GENE-EXPRESSION; INHIBITS TUMOR-GROWTH; HIGH-AFFINITY BINDING; TYROSINE-KINASE; FACTOR-B; FACTOR RECEPTOR-1; SIGNAL-TRANSDUCTION; FACTOR-I; VASCULAR-PERMEABILITY;
D O I
10.1126/scisignal.259re1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor-A (VEGF-A) is a key target for new antiangiogenic drugs for the treatment of both malignant and nonmalignant human diseases. Vascular effects of VEGF family members are mainly mediated by VEGF receptor 2 (VEGFR2). Conversely, the function and signaling of VEGFR1, which is present on endothelial and nonendothelial cells, are poorly understood. Intriguingly, two of five members in the VEGF family-VEGF-B and placental growth factor (PlGF)-are exclusive ligands for VEGFR1 and do not interact with the other VEGFRs, VEGFR2 and VEGFR3. These VEGFR1-specific ligands may be important therapeutic targets for the treatment of cancer. This Review discusses the distinctive roles of VEGFR1 and its ligands PlGF and VEGF-B in the mediation of angiogenic signaling and considers the therapeutic potential of targeting these particular vascular factors.
引用
收藏
页数:11
相关论文
共 132 条
[71]  
Limentani S, 2008, J CLIN ONCOL, V26
[72]   Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells [J].
List, AF ;
Glinsmann-Gibson, B ;
Stadheim, C ;
Meuillet, EJ ;
Bellamy, W ;
Powis, G .
EXPERIMENTAL HEMATOLOGY, 2004, 32 (06) :526-535
[73]   Age-dependent impairment of HIF-1α expression in diabetic mice:: Correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells [J].
Liu, Lixin ;
Marti, Guy P. ;
Wei, Xiaofei ;
Zhang, Xianjie ;
Zhang, Huafeng ;
Liu, Ye V. ;
Nastai, Manuel ;
Semenza, Gregg L. ;
Harmon, John W. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2008, 217 (02) :319-327
[74]   Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 [J].
Luttun, A ;
Tjwa, M ;
Moons, L ;
Wu, Y ;
Angelillo-Scherrer, A ;
Liao, F ;
Nagy, JA ;
Hooper, A ;
Priller, J ;
De Klerck, B ;
Compernolle, V ;
Daci, E ;
Bohlen, P ;
Dewerchin, M ;
Herbert, JM ;
Fava, R ;
Matthys, P ;
Carmeliet, G ;
Collen, D ;
Dvorak, HF ;
Hicklin, DJ ;
Carmeliet, P .
NATURE MEDICINE, 2002, 8 (08) :831-840
[75]   Placental growth factor (PIGF) and its receptor Flt-1 (VEGFR-1) - Novel therapeutic targets for angiogenic disorders [J].
Luttun, A ;
Tjwa, M ;
Carmeliet, P .
LYMPHATIC CONTINUUM: LYMPHATIC BIOLOGY AND DISEASE, 2002, 979 :80-93
[76]   Loss of placental growth factor protects mice against vascular permeability in pathological conditions [J].
Luttun, A ;
Brusselmans, K ;
Fukao, H ;
Tjwa, M ;
Ueshima, S ;
Herbert, JM ;
Matsuo, O ;
Collen, D ;
Carmeliet, P ;
Moons, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 295 (02) :428-434
[77]   Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth [J].
Lyden, D ;
Hattori, K ;
Dias, S ;
Costa, C ;
Blaikie, P ;
Butros, L ;
Chadburn, A ;
Heissig, B ;
Marks, W ;
Witte, L ;
Wu, Y ;
Hicklin, D ;
Zhu, ZP ;
Hackett, NR ;
Crystal, RG ;
Moore, MAS ;
Hajjar, KA ;
Manova, K ;
Benezra, R ;
Rafii, S .
NATURE MEDICINE, 2001, 7 (11) :1194-1201
[78]   Dimerization of VEGF receptors and implications for signal transduction: A computational study [J].
Mac Gabhann, Feilim ;
Popel, Aleksander S. .
BIOPHYSICAL CHEMISTRY, 2007, 128 (2-3) :125-139
[79]   ISOLATION OF A HUMAN PLACENTA CDNA CODING FOR A PROTEIN RELATED TO THE VASCULAR-PERMEABILITY FACTOR [J].
MAGLIONE, D ;
GUERRIERO, V ;
VIGLIETTO, G ;
DELLIBOVI, P ;
PERSICO, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (20) :9267-9271
[80]  
MAGLIONE D, 1993, ONCOGENE, V8, P925